AI Verdict
HRTX has stronger fundamentals based on our AI analysis.
HRTX vs HRGN Fundamental Comparison
| Metric | HRTX | HRGN |
|---|---|---|
| Revenue | $154.9M | $704,000.0 |
| Net Income | $-20.2M | $-6.9M |
| Net Margin | -13.0% | -975.7% |
| ROE | -140.9% | -649.9% |
| ROA | -7.9% | -256.6% |
| Current Ratio | 2.48x | 1.19x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-0.12 | $-0.44 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HRTX vs HRGN: Frequently Asked Questions
Is HRTX or HRGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HRTX has stronger fundamentals. HRTX is rated STRONG SELL (87% confidence) while HRGN is rated STRONG SELL (85% confidence). This is not investment advice.
How does HRTX compare to HRGN fundamentally?
HERON THERAPEUTICS, INC. /DE/ has ROE of -140.9% vs Harvard Apparatus Regenerative Technology, Inc.'s -649.9%. Net margins are -13.0% vs -975.7% respectively.
Which stock pays higher dividends, HRTX or HRGN?
HRTX has a dividend yield of N/A or no dividend while HRGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HRTX or HRGN for long term?
For long-term investing, consider that HRTX has STRONG SELL rating with 87% confidence, while HRGN has STRONG SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HRTX vs HRGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HRTX vs HRGN, the AI consensus favors HRTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.